Zanubrutinib 80mg capsules
NHS hospitals in England used £134,370,752 of indicative cost of Zanubrutinib 80mg capsules in the 12 months to April 2026, about 0.5% of all hospital medicines spend. That is up 76.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Zanubrutinib 80mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Zanubrutinib 80mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Western Sussex Hospitals Nhs Found Trust | £3,803,234 |
| Univ Hpl B/Ham Nhs Foundation Trust | £3,326,839 |
| The Christie Nhs Foundation Trust | £3,269,256 |
| Hull And East Yorkshire Hpls Nhs Trust | £3,173,968 |
| University College London Foundation Tr | £2,777,155 |
| University Hpls Of Leicester Nhs Trust | £2,731,951 |
| East Sussex Healthcare Nhs Trust | £2,507,615 |
| University Hospitals Dorset Nhs Ft | £2,458,246 |
| The Clatterbridge Cancer Centre Nhs Ft | £2,293,588 |
| Norfolk & Norwich University Hpl Nhs Trt | £2,262,250 |
The primary-care picture
Zanubrutinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Zanubrutinib medicine page.